Table:
begin	end	state
1	11	non-cytoplasmic
12	43	transmembrane
44	55	cytoplasmic
56	80	transmembrane
81	103	non-cytoplasmic
104	134	transmembrane
135	145	cytoplasmic
146	170	transmembrane
171	181	non-cytoplasmic
182	206	transmembrane
207	225	cytoplasmic
226	252	transmembrane
253	257	non-cytoplasmic
258	276	transmembrane
277	289	cytoplasmic
290	310	transmembrane
311	329	non-cytoplasmic
330	350	transmembrane
351	351	cytoplasmic
352	398	transmembrane
399	404	non-cytoplasmic
405	408	cytoplasmic
409	410	non-cytoplasmic
411	433	transmembrane
434	497	non-cytoplasmic

Input:
>WP_020922288.1 NCBI__GCF_000092045.1:WP_020922288.1
MFDFGIIPPAMFLGMVIFMLYGFPVAFSLAAVGMFFGIIGIVTGHFSEAFLQALPLRFFG
IVSNDLLLAIPFFTLMGAVLERCGLAEDLLEGTGKLFGGIPGGLAYAVILVGAVLGAITG
TVAASVITMGVISLPIMLRYGYSPRLATGVIAASGTITQVIPPSLVLVVLADQLGRSVGD
MYLGAIGPSILQVTIFVLFVLVMSIVRPKSMPPLPKEVRGDFNWALLVKVLMGMVPSIVL
IFLVLGTIFMGLATPTEAGALGVVGAMLLAAMNRRLTWPLIREAMTSTTHITSMVVMILI
GSTCFSLVFQGMDGSRWIEHMLSGIPGGPVGFLIFVNIFIFVLAFFLDFFEIAFIVIPML
APVASSLGIDLIWFGVLICVNMQTSFMHPPFGFALFYLRSIASKDVKTSDIYMGALPWVG
MQIILVAIVIFWPQSVTYWLDHGPKVDPNSIKIEVPGFGGQLGLPPVGGGGNGAPQIPGL
TLPPLNGLPGAPPPPAK

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server